CME Presentations

MDD


Presentations


Speakers

  • Anthony Rothschild, MD

    Anthony Rothschild, MD

    Anthony Rothschild, MD

    Irving S. and Betty Brudnick Endowed Chair

    Anthony Rothschild, M.D. is the Irving S. and Betty Brudnick Endowed Chair, Professor of Psychiatry, and Psychiatry Department Vice Chair for Research at the University of Massachusetts Medical School and its clinical partner, UMass Memorial Medical Center. Dr. Rothschild has published his work in numerous scientific journals including the American Journal of Psychiatry, Archives of General Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, and others. He has received many awards and honors including the Massachusetts Psychiatric Society Outstanding Psychiatrist Award for Research, numerous teaching and mentoring awards, and has been consistently named to the Best Doctors of America and Boston Magazine, Best Doctors.
  • W. Clay Jackson, MD, DipTh

    W. Clay Jackson, MD, DipTh

    W. Clay Jackson, MD, DipTh

    Clinical Assistant Professor, Family Medicine and Psychiatry

    W. Jackson, MD, DipTh, is a Clinical Assistant Professor of Family Medicine and Psychiatry at the University of Tennessee College of Medicine (UTCM) in Memphis, Tennessee, where he maintains a private practice in family medicine and directs the palliative medicine program at the West Cancer Center. Dr. Jackson also serves as the Associate Fellowship Director for Palliative Medicine at UTCM. From this professional platform, he leads multiple teams of dedicated clinicians who have helped to transform the experience of seriously ill patients in the Mid-South. Furthermore, Dr. Jackson has published his research in many journals such as Family Medicine and the Journal of Affective Disorders, has served as Editor in Chief of The Pain Practitioner, and has co-authored a book on family dynamics.

CME Information

   
Global LogoPQH Logo

Harmonizing Physician Goals with Patient Expectations

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the Depression and Bipolar Support Alliance (DBSA).

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Sage Therapeutics Inc. and Biogen.

DATE OF RELEASE/EXPIRATION

This activity was released on March 30, 2022 and is valid until March 30, 2023. Requests for credit must be made no later than March 30, 2023

TARGET AUDIENCE

The educational design of this activity addresses the needs of Psychologists, psychiatrists, primary care physicians, nurse practitioners, physician assistants, and mental-health specialists involved in the treatment of patients with MDD.

STATEMENT OF NEED/PROGRAM OVERVIEW

Major depressive disorder (MDD) is a common but serious mood disorder with a rising prevalence in the US and around the world. Unfortunately, the current standard of care is often limited by a failure to achieve remission, residual symptoms, high likelihood of recurrence, and side effects. In addition, MDD may worsen the disease course of comorbid conditions and is associated with higher mortality in patients with chronic medical illnesses. For many patients, a disconnect exists between their treatment expectations and actual outcomes.

Join an expert panel of clinicians and patient representatives for 2 CME activities on MDD, the shortfalls of current management, emerging treatments that could improve clinical outcomes and quality of life, and strategies to incorporate patient perspectives into treatment plans.

Session 2, “Harmonizing Physician Goals with Patient Expectations,” will help clinicians facilitate multidisciplinary care for their patients to effectively deal with treatment side effects and common comorbidities associated with MDD. Expert panelists will also provide strategies on integrating patient perspectives and priorities into individualized treatment plans to enhance health outcomes and quality of life for patients with MDD.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

  • Discuss strategies to ensure comprehensive care-team management of MDD
  • Integrate patient perspectives and priorities into individualized treatment strategies

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship
Anthony J. Rothschild, M.D
Irving S. and Betty Brudnick Endowed Chair and Professor of Psychiatry
Vice Chair-for Research, Department of Psychiatry
Editor-in-Chief, Journal of Clinical Psychopharmacology
University of Massachusetts Chan Medical School
And UMass Memorial Health Care
Consulting Fee: Alkermes, Janssen, Sage Therapeutics, Xenon Pharmaceuticals Contracted Research: Janssen, Otsuka, Praxis
W. Clay Jackson, MD, DipTh
Clinical Assistant Professor of Family Medicine and Psychiatry
University of Tennessee College of Medicine
Consulting Fee: Abbvie, Alkermes, Allergan, Genentech, Otsuka, Sunovion

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Carole Drexel Nothing to disclose
Eve Wilson Nothing to disclose
Caroline Laurendeau Nothing to disclose
Bonnie Rosenthal-Patient Participant Nothing to disclose
Olivia Eiler-Patient Participant Nothing to disclose


DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Technical Support:

For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive.com at 877-394-1306 or at Support@PsychiatryCareLive.com.
    
Global LogoPQH Logo

Exploring New Approaches for MDD Treatment

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the Depression and Bipolar Support Alliance (DBSA).

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Sage Therapeutics Inc. and Biogen.

DATE OF RELEASE/EXPIRATION

This activity was released on March 30, 2022 and is valid until March 30, 2023. Requests for credit must be made no later than March 30, 2023

TARGET AUDIENCE

The educational design of this activity addresses the needs of Psychologists, psychiatrists, primary care physicians, nurse practitioners, physician assistants, and mental-health specialists involved in the treatment of patients with MDD.

STATEMENT OF NEED/PROGRAM OVERVIEW

Major depressive disorder (MDD) is a common but serious mood disorder with a rising prevalence in the US and around the world. Unfortunately, the current standard of care is often limited by a failure to achieve remission, residual symptoms, high likelihood of recurrence, and side effects. In addition, MDD may worsen the disease course of comorbid conditions and is associated with higher mortality in patients with chronic medical illnesses. For many patients, a disconnect exists between their treatment expectations and actual outcomes.

Join an expert panel of clinicians and patient representatives for 2 CME activities on MDD, the shortfalls of current management, emerging treatments that could improve clinical outcomes and quality of life, and strategies to incorporate patient perspectives into treatment plans.

Session 1, “Exploring New Approaches for MDD Treatment,” will examine the burden of MDD on patients, review current treatments and associated limitations, and explore the role of neuroactive steroids and emerging clinical safety and efficacy data related to their use in MDD.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

  • Describe the burden of MDD and the need for new treatment options
  • Assess the potential role of neuroactive steroids in the alleviation of depressive symptoms

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship
Anthony J. Rothschild, M.D
Irving S. and Betty Brudnick Endowed Chair and Professor of Psychiatry
Vice Chair-for Research, Department of Psychiatry
Editor-in-Chief, Journal of Clinical Psychopharmacology
University of Massachusetts Chan Medical School
And UMass Memorial Health Care
Consulting Fee: Alkermes, Janssen, Sage Therapeutics, Xenon Pharmaceuticals Contracted Research: Janssen, Otsuka, Praxis
W. Clay Jackson, MD, DipTh
Clinical Assistant Professor of Family Medicine and Psychiatry
University of Tennessee College of Medicine
Consulting Fee: Abbvie, Alkermes, Allergan, Genentech, Otsuka, Sunovion

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Carole Drexel Nothing to disclose
Eve Wilson Nothing to disclose
Caroline Laurendeau Nothing to disclose
Bonnie Rosenthal-Patient Participant Nothing to disclose
Olivia Eiler-Patient Participant Nothing to disclose


DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Technical Support:

For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive.com at 877-394-1306 or at Support@PsychiatryCareLive.com.